An example is the development of immunoregulators (epitope peptides of MBP and MOG) for Multiple Sclerosis, which serve as platforms for the design, synthesis, and development of MS therapeutics and vaccines [56,57,58,59,60,61,62,63,64]. This evidence concerns the gene MOG and myeloid sarcoma.